Advertisement

Advertisement

Quick Chats

hematologic malignancies
immunotherapy

By The ASCO Post Staff  / Quick Chats

Andrew D. Zelenetz, MD, PhD, and Stephen J. Schuster, MD, on CAR T Cells for Hematologic Malignancies: Where We’re At

multiple myeloma

By The ASCO Post Staff  / Quick Chats

Paul G. Richardson, MD, and Peter M. Voorhees, MD, on Multiple Myeloma: Surveying the Evolving Landscape of Up-Front Drugs

colorectal cancer
gastrointestinal cancer

By The ASCO Post Staff  / Quick Chats

Heinz-Josef Lenz, MD, and Axel Grothey, MD, on Liquid Biopsies for Colorectal and Other GI Cancers

colorectal cancer
genomics/genetics

By The ASCO Post Staff  / Quick Chats

Heinz-Josef Lenz, MD, and Axel Grothey, MD, on Colorectal Cancer: Molecular Testing and Interpreting an NGS Report

Advertisement

Advertisement



Oct
20
Today In Oncology
PARP Rechallenge Slows Ovarian Cancer Progression in Platinum-Sensitive Disease
Preclinical Study Examines Relationship Between Aging Breast Tissue and Invasive Breast Cancer
Primary Tumor Resection Followed by Systemic Treatment vs Systemic Treatment in Metastatic Colorectal Cancer 60-Day Mortality
First-Line Fulvestrant/Palbociclib vs Letrozole/Palbociclib for Endocrine-Sensitive, HR-Positive, HER2-Negative Advanced Breast Cancer
Global Analysis of National Health System Characteristics and Breast Cancer Mortality and Stage at Diagnosis
View More 
Advertisement
© 2021 HSP News Service, L.L.C.
Designed by Harborside